Vega GL - Search Results

1

Body size misperception: a novel determinant in the obesity epidemic.

Powell TM, de Lemos JA, Banks K, Ayers CR, Rohatgi A, Khera A, McGuire DK, Berry JD, Albert MA, Vega GL, Grundy SM, Das SR. Powell TM, et al. Among authors: vega gl. Arch Intern Med. 2010 Oct 11;170(18):1695-7. doi: 10.1001/archinternmed.2010.314. Arch Intern Med. 2010. PMID: 20937931 Free PMC article. No abstract available.

2

Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids.

Gylling H, Vega GL, Grundy SM. Gylling H, et al. Among authors: vega gl. J Lipid Res. 1992 Oct;33(10):1527-39. J Lipid Res. 1992. PMID: 1431577 Free article.

3

Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.

Vega GL, Grundy SM. Vega GL, et al. J Intern Med. 1992 Nov;232(5):405-13. doi: 10.1111/j.1365-2796.1992.tb00606.x. J Intern Med. 1992. PMID: 1453124

4

Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.

Grundy SM, Vega GL. Grundy SM, et al. Among authors: vega gl. Arch Intern Med. 1992 Jan;152(1):28-34. Arch Intern Med. 1992. PMID: 1728925 Review.

5

What is meant by overproduction of apo B-containing lipoproteins?

Grundy SM, Vega GL. Grundy SM, et al. Among authors: vega gl. Adv Exp Med Biol. 1991;285:213-22. doi: 10.1007/978-1-4684-5904-3_26. Adv Exp Med Biol. 1991. PMID: 1858551 Review. No abstract available.

6

Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia.

Vega GL, Grundy SM. Vega GL, et al. J Intern Med. 1991 Oct;230(4):341-50. doi: 10.1111/j.1365-2796.1991.tb00454.x. J Intern Med. 1991. PMID: 1919427

7

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins.

Vega GL, Krauss RM, Grundy SM. Vega GL, et al. J Intern Med. 1990 Feb;227(2):81-94. doi: 10.1111/j.1365-2796.1990.tb00124.x. J Intern Med. 1990. PMID: 2105373 Clinical Trial.

8

Role of apolipoprotein levels in clinical practice.

Grundy SM, Vega GL. Grundy SM, et al. Among authors: vega gl. Arch Intern Med. 1990 Aug;150(8):1579-82. Arch Intern Med. 1990. PMID: 2116784 Review. No abstract available.

9

Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia.

Grundy SM, Vega GL, Garg A. Grundy SM, et al. Among authors: vega gl. Am J Cardiol. 1990 Sep 18;66(8):31B-38B. doi: 10.1016/0002-9149(90)90438-7. Am J Cardiol. 1990. PMID: 2206034 Review.

10

Does measurement of apolipoprotein B have a place in cholesterol management?

Vega GL, Grundy SM. Vega GL, et al. Arteriosclerosis. 1990 Sep-Oct;10(5):668-71. doi: 10.1161/01.atv.10.5.668. Arteriosclerosis. 1990. PMID: 2206113 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page